Twelve years of fluconazole in clinical practice: Global-trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida

Clinical Microbiology and Infection

Volumn 10, Issue SUPPL. 1, 2004, Pages 11-23

  Pfaller, Michael A ^a   Diekema, D J ^a   Steele Moore, L ^b   Denys, G ^c   Staley, C ^d   Dipersio, J R ^e   Saubolle, M ^f   Wilson, M L ^g   Overturf, G D ^h   Peterson, L R ⁱ   Schreckenberger, P C ^j   Doern, G V ^k   Cavalieri, S ^l   Kehl, S ^m   Brecher, S ⁿ   Lee, L ^o   Isenberg, H ^p   Hardy, D ^q   Koga, D S ^r   Fusco, J ^s   Hoffmann, M ^t   Swanzy, S ^u   Murray, P R ^v   Southern, P ^w   Wanger, A ^x   Reisner, B ^y   Snyder, J ^z   Jenkin, S ^aa   Hazen, K ^ab   Rennie, R ^ac   Hoban, D ^ad   Davidson, R ^ae   Toye, B ^af   Simor, A ^ag   Richardson, S ^ah   Robson, H ^ai   Smayvsky, J ^aj   Casellas, J M ^ak   Sampaio, J L M ^al   Prado, V ^am   Garcia, P ^an   Robledo, J A ^ao   Osornio, J S ^ap   Zoccoli, C ^aq   Reis, A ^ar   Guzman, M ^as   Schwab, D A ^at   Carroll, K ^au   Chapin Robertson, K ^av   Bourbeau, P ^aw   Sharp, S E ^ax   Barth, A L ^ay   Struelens, M J ^ay   Jarlier, V ^az   Nguyen, J ^az   Roussel Delvallez, M ^ba   Legakis, N ^bb   Keller, N ^bc   Pascual, A ^bd   Linares, J ^be   Canton, R ^bf   Prapian, F ^bg   Bille, J ^bg   Gur, D ^bh   Korten, V ^bi   Mulazimoglu, L ^bi   Unal, S ^bh   Kocagoz, S ^bh   Debbia, E ^bj   French, G ^bk   Etienne, J ^bl   Raponi, G ^bm   Rankin, I ^bn   Nicoletti, G ^bo   Fadda, G ^bp   Hanberger, H ^bq   Rangel Fausto, S ^br   Rodloff, A C ^bs   Smyth, E ^bt   Christiansen, K ^bu,bv,bw   Coombs, G ^bu,bv,bw   Kohno, S ^bx   Miyazaki, Y ^bx   Schmitz, F J ^by,bz   Fluit, A C ^ca   Costa, D ^cb,cc   Appelbaum, P ^cd   Bruckner, D ^ce   Chaturvedi, V ^cf   Hall, G ^cg   Kauffman, C ⁿ   Sobel, I ^ch   Suh, B ^ci   Van Horn, K ^cj   Finquelievich, J ^ck   Tiraboschi, I N ^cl   Colombo, A L ^cm   Crewe Brown, H H ^cn   Roditi, D ^co   more..

^a UNIVERSITY OF IOWA   (United States)

^b CHRISTIANA CARE HEALTH SYSTEM   (United States)

^c METHODIST HOSPITAL   (United States)

^d HENRY FORD HOSPITAL   (United States)

^e Suma Health System   (United States)

^f Good Scamaritan Reg Medical Ctr   (United States)

^g DENVER HEALTH MEDICAL CENTER   (United States)

^h UNIVERSITY OF NEW MEXICO HOSPITAL   (United States)

ⁱ NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^j UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^k UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^l CREIGHTON UNIVERSITY   (United States)

^m FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

ⁿ VETERANS AFFAIRS MEDICAL CENTER   (United States)

^o New York Presbyterian Hospital Columbia University Medical Center   (United States)

^p LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^q STRONG MEMORIAL HOSPITAL   (United States)

^r ST JUDE MEDICAL CENTER   (United States)

^s KAISER PERMANENTE   (United States)

^t SACRED HEART MEDICAL CENTER   (United States)

^u UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^v BARNES JEWISH HOSPITAL   (United States)

^w PARKLAND HEALTH AND HOSPITAL SYSTEM   (United States)

^x UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^y UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^z UNIVERSITY OF LOUISVILLE HOSPITAL   (United States)

^aa CAROLINAS MEDICAL CENTER   (United States)

^ab UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

^ac UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^ad HEALTH SCIENCES CENTRE   (Canada)

^ae QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^af UNIVERSITY OF OTTAWA   (Canada)

^ag SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^ah HOSPITAL FOR SICK CHILDREN   (Canada)

^ai ROYAL VICTORIA HOSPITAL   (Canada)

^aj CEMIC   (Argentina)

^ak Centro Estudios en Antimicrobianos   (Argentina)

^al Lamina Laboratory   (Brazil)

^am Unidad De Microbiologia Oriente   (Chile)

^an Centro Diagnostico   (Chile)

^ao Corp Para Investig Biblogicag ^*  (Colombia)

^ap Istituto Nacional de la Nutricion   (Mexico)

^aq Laboratorio Medico Santa Luzia   (Brazil)

^ar FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^as Centro Medico Docente La Trinidad   (Venezuela)

^at Pathology Medical Laboratories   (United States)

^au UNIVERSITY OF UTAH HOSPITAL   (United States)

^av LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^aw GEISINGER MEDICAL CENTER   (United States)

^ax MOUNT SINAI MEDICAL CENTER   (United States)

^ay HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^az ERASME HOSPITAL   (Belgium)

^ba PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^bb UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^bc SHEBA MEDICAL CENTER   (Israel)

^bd Hospital V Macarena   (Spain)

^be HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^bf HOSPITAL RAMÓN Y CAJAL   (Spain)

^bg LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^bh HACETTEPE UNIVERSITY   (Turkey)

^bi MARMARA UNIVERSITY   (Turkey)

^bj UNIVERSITY OF GENOA   (Italy)

^bk ST THOMAS HOSPITAL   (United Kingdom)

^bl EDOUARD HERRIOT HOSPITAL   (France)

^bm Institute of Microbiology   (Italy)

^bn MOUNT SINAI MEDICAL CENTER   (United States)

^bo UNIVERSITY OF CATANIA   (Italy)

^bp FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^bq LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^br Epiderniologia Hospitalaria   (Mexico)

^bs Institut fur Medizinische Informatik   (Germany)

^bt BEAUMONT HOSPITAL   (Ireland)

^bu INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^bv Inst F Med Mikrobiol und Hygiene   (Austria)

^bw ROYAL PERTH HOSPITAL   (Australia)

^bx NAGASAKI UNIVERSITY   (Japan)

^by UNIVERSITY OF FREIBURG   (Germany)

^bz HEINRICH HEINE UNIVERSITY   (Germany)

^ca UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^cb MILPARK HOSPITAL   (South Africa)

^cc CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^cd PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^ce UCLA MEDICAL CENTER   (United States)

^cf NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^cg LERNER RESEARCH INSTITUTE   (United States)

^ch HARPER UNIVERSITY HOSPITAL   (United States)

^ci TEMPLE UNIVERSITY   (United States)

^cj WESTCHESTER MEDICAL CENTER   (United States)

^ck Scaolabrine Ortiz   (Argentina)

^cl UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^cm Univ of Iowa College of Medicine ^*  (Brazil)

^cn NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^co UNIVERSITY OF CAPE TOWN   (South Africa)

more..

Author keywords

Candidemia; Fluconazole; Surveillance

Indexed keywords

FLUCONAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; ASIA; CANADA; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA GUILLIERMONDII; CANDIDA KEFYR; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA RUGOSA; CANDIDA SAKE; CANDIDA TROPICALIS; CANDIDA ZEYLANOIDES; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG SENSITIVITY; EUROPE; FUNGEMIA; FUNGUS ISOLATION; GEOGRAPHY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PACIFIC ISLANDS; PRIORITY JOURNAL; SOUTH AND CENTRAL AMERICA; SPECIES DISTRIBUTION; TIME; UNITED STATES;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA INCONSPICUA; CANDIDA PARAPSILOSIS; CANDIDA RUGOSA; CANDIDA SAKE; CANDIDA TROPICALIS; CANDIDA ZEYLANOIDES;

EID: 12144286534     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1470-9465.2004.t01-1-00844.x     Document Type: Article

References (49)

1. Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiologic features of invasive mycotic infections in the San Francisco Bay Area: results of a population-based laboratory active surveillance 1992-93. Clin Infect Dis 1998; 27: 1138-47.
2. Blumberg HM, Jarvis WR, Soucie JM et al. and the NEMIS Study Group. Risk factors for candidal blood stream infections in surgical intensive care unit patients: The NEMIS Prospective Multicenter Study. Clin Infect Dis 2001; 33: 177-86.
3. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999; 29: 239-44.
4. Rangel-Frausto MS, Wiblin T, Blumberg HM et al. National Epidemiology of Mycoses Survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units. Clin Infect Dis 1999; 29: 253-8.
5. Sandven P. Epidemiology of candidemia. Rev Iberoam Micol 2000; 17: 73-81.
6. Diekema DJ, Messer SA, Brueggemann AB et al. Epidemiology of candidemia: Three-year results from the Emerging Infections and the Epidemiology of Iowa Organisms study. J Clin Microbiol 2002; 40: 1298-302.
7. Hajjeh RA The changing epidemiology of candidemia [abstract S-6]. In: 6th ASM Conference on Candida and Candidiasis. Washington DC : American Society for Microbiology. 2002: 15.
8. Kao AS, Brandt ME, Pruitt WR et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 1999; 29: 1164-70.
9. Lyon GM, Ponce-DeLeon G, Sofaia AN et al. Population-based surveillance for Candida bloodstream infections: Trends in incidence of disease and azole resistance [abstract 217]. In: 40th Interscience Conference on Antimicrobial Agents Chemothertherapy Washington, DC: American Society for Microbiology, 2000.
10. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital acquired candidemia: attributable mortality and excess length of stay. Arch Intern Med 1998; 148: 2642-5.
11. Rex JH, Walsh TJ, Sobel JD et al. Practice guidelines for the treatment of candidiasis. Clin Infect Dis 2000; 30: 662-78.
12. Sheehan DJ, Hitchcock CA, Sibley CM. Current and emerging azole antifungal agents. Clin Microbiol Rev 1999; 12: 40-79.
13. Edwards JE, Bodey GP, Bowden RA et al. International conference for the development of a consensus on the management and prevention of severe candidal infections. Clin Infect Dis 1997; 25: 43-59.
14. Meis J, Petrou M, Bille J, Ellis D, Gibbs D. Global Antifungal Surveillance Group. A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Diagn Microbiol Infect Dis 2000; 36: 215-23.
15. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995; 39: 1-8.
16. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997; 24: 1122-8.
17. Boschman CR, Bodnar UR, Tornatore MA et al. Thirteen-years evolution of azole resistance in yeast isolates and prevalence of resistant strains carried by cancer patients at large medical center. Antimicrob Agents Chemother 1998; 42: 734-8.
18. Nguyen MH, Peacock JE, Morris AJ et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996; 100: 617-23.
19. Powderly WG. Resistant candidiasis. AIDS. Res Hum Retroviruses 1994; 10: 925-9.
20. Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2002; 2: 73-85.
21. White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998; 11: 382-402.
22. Pfaller MA, Rhine CJ, Redding SW et al. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol 1994; 32: 59-64.
23. Redding S, Smith J, Farinacci G et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS. documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis 1994; 18: 240-2.
24. Redding SW, Pfaller MA, Messer SA et al. Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering from one or more episodes of infection. J Clin Microbiol 1997; 35: 1761-5.
25. Marr KA, White TC, van Burik JAH, Bowden RA. Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow-transplantation. Clin Infect Dis 1997; 25: 908-10.
26. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 1998; 31: 327-32.
27. Pfaller MA, Messer SA, Hollis RJ et al. Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. Diagn Microbiol Infect Dis 1999; 33: 217-22.
28. Chryssanthous E. Trends in antifungal susceptibility among Swedish Candida species bloodstream isolates from 1994 to 1998: Comparison of the Etest and the Sensititre Yeast One Colorimetric Antifungal Panel with the NCCLS M-27A reference method. J Clin Microbiol 1994; 39: 4181-3.
29. Pfaller MA, Messer SA, Hollis RJ, Jones RN, Diekema DJ. In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. Antimicrob Agents Chemother 2002; 46: 1723-7.
30. Pfaller MA, Diekema DJ. The role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. J Clin Microbiol 2002; 40: 3551-7.
31. St. Germain G, Laverdiere M, Pellertier R et al. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year, 1996-8, multicenter surveillance study in Quebec. Can J Clin Microbiol 2001; 39: 949-53.
32. Berrouane YF, Herwaldt LA, Pfaller MA. Trends in antifungal use and epidemiology of nosocomial yeast infections in a University hospital. J Clin Microbiol 1999; 37: 531-7.
33. Pfaller MA, Diekema DJ, Jones RN, Sader HS et al. The SENTRY Participant Group. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program. J Clin Microbiol 2001; 39: 3254-9.
34. Sanglard D, Ischer F, Calabrese D, Majcherczyk PA, Bille J. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob Agents Chemother 1999; 43: 2753-65.
35. Ellis D, Marriott D, Hajjeh RA, Warnock D, Meyer W, Barton R. Epidemiology: surveillance of fungal infections. Med Mycol 2000; 38 (Suppl. 1): 173-82.
36. Pfaller MA. The epidemiology of invasive mycosis-narrowing the gap. Clin Infect Dis 1998; 27: 1148-50.
37. Jones RN. Detection of emerging resistance patterns within longitudinal surveillance systems: data sensitivity and microbial susceptibility. J Antimicrob Chemother 2000; 46(T2): 1-8.
38. Jones RN, Masterton R. Determining the value of antimicrobial surveillance programs. Diagn Microbiol Infect Dis 2001; 41: 171-5.
39. Blignaut E, Pujol C, Lockhart S, Joly S, Soll DR. Ca3 fingerprinting of Candida albicans isolates from Human Immunodeficiency Virus-positive and healthy individuals reveals a new clade in South Africa. J Clin Microbiol 2002; 40: 826-36.
40. Pujol C, Pfaller M, Soll DR. Ca3 fingerprinting of Candida albicans blood stream isolates from the U.S., Canada, South America, and Europe reveals a 'European' clade. J Clin Microbiol 2002; 40: 2729-40.
41. Warren NG, Hazen KC. Candida, Cryptococcus, and other yeasts of medical importance. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology, 7th edn. Washington: DC. ASM Press; 1999: 1184-99.
42. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved standard. NCCLS publication no. M27-A. Wayne, PA: NCCLS 1997.
43. Rex JH, Pfaller MA, Galgiani JN et al. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro/in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin Infect Dis 1997; 24: 235-47.
44. Colombo AL, Nucci M, Salomao R. High rate of non-albicans candidemia in Brazilian tertiary care hospitals. Diagn Microbiol Infect Dis 1999; 34: 281-6.
45. Kauffman CA. Fungal infections in older adults. Clin Infect Dis 2001; 33: 550-5.
46. Lockhart SR, Joly S, Vargas K, Swails-Wenger J, Enger L, Soll DR. Defenses against oral Candida carriage break down in the elderly. J Dent Res 1999; 78: 857-68.
47. Denning DW. Can we prevent azole resistance in fungi? Lancet, 1995; 346: 454-5.
48. Baddley JW, Smith AM, Moser SA, Pappas PG. Trends in frequency and susceptibilities of Candida glabrata blood-stream isolates at a University Hospital. Diagn Microbiol Infect Dis, 2001; 39: 199-201.
49. Martins MD, Lozano-Chiu M, Rex JH. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans. Clin Infect Dis 1998; 27: 1291-4.